Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak



The drop is a sharp reversal of a massive 2026 stock rally fueled by optimism over its personalized cancer vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *

Prove your humanity: 9   +   8   =